BTIG Starts Senseonics Holdings (SENS) at Buy

BTIG initiated coverage on Senseonics Holdings (NYSE: SENS) with a Buy rating and a price target of $4.50.

Analyst Sean Lavin said, "We believe implanted CGM (Senseonics should be first to market) could offer better compliance and glucose control in some patients. While ICGM may benefit all diabetics and has a huge potential market, it may see very strong traction in less compliant patients such as the young and the elderly. We see shares as a bit binary with more upside than downside and feel the biggest risk will be getting endocrinologists to do procedures."

For an analyst ratings summary and ratings history on Senseonics Holdings click here. For more ratings news on Senseonics Holdings click here.

Shares of Senseonics Holdings closed at $2.97 yesterday.

You May Also Be Interested In

• B.Riley Starts Weave Communications Inc (WEAV) at Buy
• TD Cowen Reiterates Buy Rating on Broadcom Limited (AVGO), neutral into the print
• Stifel Downgrades Weave Communications Inc (WEAV) to Hold